Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 1251 to 1300 of 1898

TitleReference numberPublishedLast updated
Transition between inpatient hospital settings and community or care home settings for adults with social care needsNG27
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis CTA365
Vortioxetine for treating major depressive episodesTA367
Ledipasvir–sofosbuvir for treating chronic hepatitis CTA363
Implantation of a corneal graft–keratoprosthesis for severe corneal opacity in wet blinking eyesIPG534
Living-donor liver transplantationIPG535
Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retentionIPG536
Children's attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into careNG26
Blood transfusionNG24
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesionsDG19
Older people with social care needs and multiple long-term conditionsNG22
Tolvaptan for treating autosomal dominant polycystic kidney diseaseTA358
Idelalisib for treating chronic lymphocytic leukaemiaTA359
Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal)TA362
Implanting a baroreceptor stimulation device for resistant hypertensionIPG533
Developing and updating local formulariesMPG1
Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onsetNG16
Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay)DG18
Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancerIPG532
Home care: delivering personal care and practical support to older people living in their own homesNG21
Coeliac disease: recognition, assessment and managementNG20
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapyTA352
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)TA353
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolismTA354
Preoperative high dose rate brachytherapy for rectal cancerIPG531
Transcranial direct current stimulation (tDCS) for depressionIPG530
Antimicrobial stewardship: systems and processes for effective antimicrobial medicine useNG15
Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean sectionIPG528
Joint distraction for knee osteoarthritis without alignment correctionIPG529
Naloxegol for treating opioid‑induced constipationTA345
Aflibercept for treating diabetic macular oedemaTA346
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancerTA347
Everolimus for preventing organ rejection in liver transplantationTA348
Secukinumab for treating moderate to severe plaque psoriasisTA350
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)TA351
Suture fixation of acute disruption of the distal tibiofibular syndesmosisIPG521
Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosisIPG523
Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolismIPG524
Electrotherapy for the treatment of haemorrhoidsIPG525
Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headacheIPG527
Insertion of an epiretinal prosthesis for retinitis pigmentosaIPG519
Radiofrequency ablation for gastric antral vascular ectasiaIPG520
Omalizumab for previously treated chronic spontaneous urticariaTA339
Vedolizumab for treating moderately to severely active ulcerative colitisTA342
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolismTA341
Lower urinary tract symptoms in men: managementCG97
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemiaTA343
Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challengesNG11
Violence and aggression: short-term management in mental health, health and community settingsNG10
Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantationIPG516

Results per page

  1. 10
  2. 25
  3. 50
  4. All